Antiphospholipid Syndrome

被引:56
|
作者
George, Diane [1 ]
Erkan, Doruk [2 ]
机构
[1] Yale Univ, Dept Rheumatol, Sch Med, New Haven, CT 06520 USA
[2] Cornell Univ, Weill Med Coll, Hosp Special Surg, Barbara Volcker Ctr Women & Rheumat Dis, New York, NY 10021 USA
关键词
Antiphospholipid syndrome; Anticardiolipin antibodies; Lupus anticoagulant; Myocardial infarction; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERNATIONAL CONSENSUS STATEMENT; PRIMARY THROMBOSIS PREVENTION; ACUTE MYOCARDIAL-INFARCTION; LIBMAN-SACKS ENDOCARDITIS; CORONARY-ARTERY-DISEASE; ANTIBODY-SYNDROME; RISK-FACTORS; ANTICARDIOLIPIN ANTIBODIES; CLASSIFICATION CRITERIA;
D O I
10.1016/j.pcad.2009.06.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antiphospholipid syndrome (APS) is an autoimmune systemic disease that is diagnosed when there is vascular thrombosis and/or pregnancy morbidity occurring with persistently positive antiphospholipid antibodies (aPL) (lupus anticoagulant test, anticardiolipin antibodies, and/or anti-β2-glycoprotein I antibodies). Although International APS Classification Criteria have been formulated to provide a uniform approach to APS research, aPL may cause a spectrum of clinical manifestations, some of which are not included in these criteria. The main aPL-related cardiac manifestations include valve abnormalities (vegetations and/or thickening), myocardial infarction (MI), intracardiac thrombi, and myocardial microthrombosis. In this article, we will review the definition, etiopathogenesis, clinical manifestations, diagnosis, and treatment of aPL-related clinical events with emphasis on cardiac manifestations. © 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:115 / 125
页数:11
相关论文
共 50 条
  • [1] ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME
    ASHERSON, RA
    CERVERA, R
    GHARAVI, AE
    ANNALES DE MEDECINE INTERNE, 1993, 144 (05): : 367 - 376
  • [2] Antiphospholipid Antibody and Antiphospholipid Syndrome
    吴竞生
    血栓与止血学, 2008, 14 (06) : 243 - 245
  • [3] ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME
    HARRIS, EN
    PIERANGELI, SS
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1994, 16 (2-3): : 223 - 245
  • [4] Antiphospholipid syndrome
    Specker, C.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 (01): : 41 - 50
  • [5] Antiphospholipid syndrome
    Ravelli, A
    Martini, A
    PEDIATRIC CLINICS OF NORTH AMERICA, 2005, 52 (02) : 469 - +
  • [6] ANTIPHOSPHOLIPID SYNDROME
    KHAMASHTA, MA
    HUGHES, GRV
    BRITISH MEDICAL JOURNAL, 1993, 307 (6909): : 883 - 884
  • [7] Antiphospholipid syndrome
    Khamashta, M.
    Taraborelli, M.
    Sciascia, S.
    Tincani, A.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (01): : 133 - 148
  • [8] The antiphospholipid syndrome
    Fischer, Michael J.
    Rauch, Joyce
    Levine, Jerrold S.
    SEMINARS IN NEPHROLOGY, 2007, 27 (01) : 35 - 46
  • [9] ANTIPHOSPHOLIPID SYNDROME
    WIETHOLTER, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (05) : 194 - 196
  • [10] Antiphospholipid syndrome
    Martini, A
    Ravelli, A
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1995, 21 (04): : 626 - 628